Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in STTK — Shattuck Labs, Inc.

CIK 1214717 BOSTON, MA
Back to STTK Full portfolio

Position in STTK

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$10,998,206
+$6,846,323 QoQ
Shares Held
1,584,756
+145.4% QoQ
Ownership
1.58%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#14
of 100 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in STTK Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,427,018 across 520 Biotechnology names. STTK ranks #184 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in STTK

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $10,998,206 1,584,756
2026-03-31 $4,151,883 645,705
2025-12-31 $2,256,710 618,277
2025-09-30 $1,118,421 467,959
2025-06-30 $370,623 467,959
2025-03-31 $886,747 933,419
2024-12-31 $1,102,874 911,467
2024-09-30 $3,183,584 912,202
2024-06-30 $3,489,705 904,069
2024-03-31 $4,002,777 447,738
2023-12-31 $2,641,073 370,417
2023-09-30 $521,264 342,937
2023-06-30 $1,022,711 327,792
2023-03-31 $1,017,783 346,185
2022-12-31 $796,225 346,185
2022-09-30 $892,836 330,680
2022-06-30 $1,090,341 268,557
2022-03-31 $1,951,488 458,096
2021-12-31 $3,831,108 450,189
2021-09-30 $8,792,808 431,443
2021-06-30 $10,538,212 363,512
2021-03-31 $7,128,419 243,790
2020-12-31 $12,631,963 241,022